-
Je něco špatně v tomto záznamu ?
New propanoyloxy derivatives of 5β-cholan-24-oic acid as drug absorption modifiers
L. Coufalová, L. Mrózek, L. Rárová, L. Plaček, R. Opatřilová, J. Dohnal, K. Král'ová, O. Paleta, V. Král, P. Drašar, J. Jampílek,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- buněčná membrána účinky léků metabolismus MeSH
- farmakokinetika MeSH
- hydrofobní a hydrofilní interakce MeSH
- intestinální absorpce účinky léků MeSH
- kožní absorpce účinky léků MeSH
- kyseliny cholové chemie farmakologie toxicita MeSH
- léčivé přípravky metabolismus MeSH
- lidé MeSH
- nádorové buněčné linie MeSH
- permeabilita účinky léků MeSH
- proliferace buněk účinky léků MeSH
- vztahy mezi strukturou a aktivitou MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
A series of final twelve propanoyloxy derivatives of 5β-cholan-24-oic acid (O-propanoyl derivatives of cholic acid) as potential drug absorption modifiers (skin penetration enhancers, intestinal absorption promoters) was generated by multistep synthesis. Structure confirmation of all generated compounds was accomplished by 1H NMR, 13C NMR, IR and MS spectroscopy methods. All the prepared compounds were analyzed using RP-TLC, and their lipophilicity (RM) was determined. The hydrophobicity (log P), solubility (log S), polar surface area (PSA) and molar volume (MV) of the studied compounds were also calculated. All the target compounds were tested for their in vitro transdermal penetration effect and as potential intestinal absorption enhancers. The cytotoxicity of all the evaluated compounds was evaluated against normal human skin fibroblast cells. Their anti-proliferative activity was also assessed against human cancer cell lines: T-lymphoblastic leukemia cell line and breast adenocarcinoma cell line. One compound showed selective cytotoxicity against human skin fibroblast cells and another compound possessed the highest cytotoxicity against all the tested cell lines. Only one compound expressed anti-proliferative effect on leukemia cancer cells without affecting the growth of normal cells, which should be promising in potential development of new drugs. Most of the target compounds showed minimal anti-proliferative activity (IC50>37 μM), indicating they would have moderate cytotoxicity when administered as chemical absorption modifiers. The relationships between the lipophilicity/polarity and the chemical structure of the studied compounds as well as the relationships between their chemical structure and enhancement effect are discussed in this article.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc14040918
- 003
- CZ-PrNML
- 005
- 20140110113430.0
- 007
- ta
- 008
- 140107s2013 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.steroids.2013.02.001 $2 doi
- 035 __
- $a (PubMed)23435200
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Coufalová, Lenka
- 245 10
- $a New propanoyloxy derivatives of 5β-cholan-24-oic acid as drug absorption modifiers / $c L. Coufalová, L. Mrózek, L. Rárová, L. Plaček, R. Opatřilová, J. Dohnal, K. Král'ová, O. Paleta, V. Král, P. Drašar, J. Jampílek,
- 520 9_
- $a A series of final twelve propanoyloxy derivatives of 5β-cholan-24-oic acid (O-propanoyl derivatives of cholic acid) as potential drug absorption modifiers (skin penetration enhancers, intestinal absorption promoters) was generated by multistep synthesis. Structure confirmation of all generated compounds was accomplished by 1H NMR, 13C NMR, IR and MS spectroscopy methods. All the prepared compounds were analyzed using RP-TLC, and their lipophilicity (RM) was determined. The hydrophobicity (log P), solubility (log S), polar surface area (PSA) and molar volume (MV) of the studied compounds were also calculated. All the target compounds were tested for their in vitro transdermal penetration effect and as potential intestinal absorption enhancers. The cytotoxicity of all the evaluated compounds was evaluated against normal human skin fibroblast cells. Their anti-proliferative activity was also assessed against human cancer cell lines: T-lymphoblastic leukemia cell line and breast adenocarcinoma cell line. One compound showed selective cytotoxicity against human skin fibroblast cells and another compound possessed the highest cytotoxicity against all the tested cell lines. Only one compound expressed anti-proliferative effect on leukemia cancer cells without affecting the growth of normal cells, which should be promising in potential development of new drugs. Most of the target compounds showed minimal anti-proliferative activity (IC50>37 μM), indicating they would have moderate cytotoxicity when administered as chemical absorption modifiers. The relationships between the lipophilicity/polarity and the chemical structure of the studied compounds as well as the relationships between their chemical structure and enhancement effect are discussed in this article.
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a buněčná membrána $x účinky léků $x metabolismus $7 D002462
- 650 _2
- $a proliferace buněk $x účinky léků $7 D049109
- 650 _2
- $a kyseliny cholové $x chemie $x farmakologie $x toxicita $7 D002793
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hydrofobní a hydrofilní interakce $7 D057927
- 650 _2
- $a intestinální absorpce $x účinky léků $7 D007408
- 650 _2
- $a permeabilita $x účinky léků $7 D010539
- 650 _2
- $a léčivé přípravky $x metabolismus $7 D004364
- 650 _2
- $a farmakokinetika $7 D010599
- 650 _2
- $a kožní absorpce $x účinky léků $7 D012869
- 650 _2
- $a vztahy mezi strukturou a aktivitou $7 D013329
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Mrózek, Lech $u -
- 700 1_
- $a Rárová, Lucie $u -
- 700 1_
- $a Plaček, Lukáš $u -
- 700 1_
- $a Opatřilová, Radka $u -
- 700 1_
- $a Dohnal, Jiří $u -
- 700 1_
- $a Král'ová, Katarína $u -
- 700 1_
- $a Paleta, Oldřich $u -
- 700 1_
- $a Král, Vladimír $u -
- 700 1_
- $a Drašar, Pavel $u -
- 700 1_
- $a Jampílek, Josef $u -
- 773 0_
- $w MED00004438 $t Steroids $x 1878-5867 $g Roč. 78, č. 5 (2013), s. 435-53
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/23435200 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20140107 $b ABA008
- 991 __
- $a 20140110114131 $b ABA008
- 999 __
- $a ok $b bmc $g 1005314 $s 839430
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2013 $b 78 $c 5 $d 435-53 $i 1878-5867 $m Steroids $n Steroids $x MED00004438
- LZP __
- $a Pubmed-20140107